MC38-hPD-L1(2)
Strain Information
Validation Data
Figure 1. Expression of human PD-L1 on MC38-hPD-L1 cells was confirmed by flow cytometry.
MC38-hPD-L1 cells and wild type MC38 cells were stained with species-specific anti-PD-L1 antibodies. FACS analysis shows that human PD-L1 but not mouse PD-L1 was exclusively detectable on MC38-hPD-L1 cells.
Figure 2. In vivo tumor growth curves in humanized MC38-hPD-L1 syngeneic model.
BALB/c mice were subcutaneously injected 1×106 MC38-hPD-L1 cells compared with wild type MC38 cells as control. Tumor growth was monitored by measuring tumor size from day 3 after subcutaneous implantation.
Data shows that there were no significant differences between MC38-hPD-L1 cells and wild type MC38 cells in either tumorigenicity or tumor growth.
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
